1. Home
  2. Shareholder and Investor Information
  3. Outline of Securities Matters

Shareholder and Investor Information

Outline of Securities Matters

Stock Quotes (20 min. delay) JQC powered by Stock Weather
Stock Information
Business Year January 1 through December 31
Annual Shareholders Meeting During the Month of March
Record date 31-Dec
Types of stock certificates --
Record date for surplus dividend 30-Jun
Number of shares per trading unit 100
Purchase of fractional unit shares  
Where to purchase fractional unit shares Chuo Mitsui Trust Bank Corporation Nagoya Branch
3-15-35 Sakae Naka-ku Nagoya City
Shareholder Roster Administrator Chuo Mitsui Trust Bank Corporation
3-33-1 Shiba Minato-ku Tokyo
Agent
  • Chuo Mitsui Trust Bank Corporation
  • Main office and Branches Nationwide (See Note 2)
  • Nippon Shoken Daiko Ltd. [Japan Securities Agents]
  • Main Office and Branches Nationwide
Purchase fee None
Method of public notice

Our company's notification policy is to use electronic media. However, in the event it is not possible to use electronic media due to accidents or other unavoidable reasons, we will list notices in the Nihon Keizai Shimbun.

Our URL for public notices is as follows: http://www.raqualia.co.jp

Special privileges for shareholders Not Applicable
  1. Note : Under RaQualia's Articles of Incorporation, shareholders who own fractional unit shares can only exercise the rights listed below.
    1. (1) The rights listed in Corporation Law Article 189, Paragraph 2 (All Sections),
    2. (2) The right to make demands pursuant to the provisions of Corporation Law Article 166, Paragraph 1,
    3. (3) The right to receive allotments of subscription shares in proportion to the number of shares owned by the shareholder and allotments of new stock subscription reservation rights.

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Facilities
Access
Press Release
Research & Development
Collaboration
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Anidulafungin
Ziprasidone
Dalbavancin
EP4 Antagonist
Cyclooxygenase-2 (COX-2) Inhibitor
Ghrelin Receptor Agonist
5-HT4 Partial Agonist
Acid Pump Antagonist
5-HT2B Antagonist
CB2 Agonist
Motilin Receptor Agonist
Licensing
Shareholder and Investor Information
To our Shareholders and Investors
Vision, Management Principle and Culture
Corporate Governance
Stock Quotes
Outline of Securities Matters
IR Library
IR Calendar
Disclaimer
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Corporate Introduction Video
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release
Topics